5.7(top 2%)
Impact Factor
6.2(top 2%)
extended IF
180(top 1%)
H-Index
3.7K
authors
5.2K
papers
189.9K
citations
8.3K
citing journals
93.3K
citing authors

Most Cited Articles of Oncologist

TitleYearCitations
SPIKES-A six-step protocol for delivering bad news: application to the patient with cancer20001.6K
FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma2007975
Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition2000894
The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine2009838
Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program2007743
The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective2010691
Dual kinase inhibition in the treatment of breast cancer: initial experience with the EGFR/ErbB-2 inhibitor lapatinib2004681
Management of cancer in the older person: a practical approach2000675
The role of ABC transporters in clinical practice2003619
The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies2009591
The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience2013580
Cancer-related fatigue: the scale of the problem2007575
The role of hypoxia-induced factors in tumor progression2004568
Photodynamic therapy in oncology2006544
Triple-negative breast cancer: an unmet medical need2011542
Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping2012532
Biology and therapeutic advances for pediatric osteosarcoma2004527
TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility2006510
Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response2004508
Obesity and cancer2010496
The clinical approach towards chondrosarcoma2008488
Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy2003481
Beyond costs and benefits: understanding how patients make health care decisions2010476
FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome2018464
Vascular endothelial growth factor as a target for anticancer therapy2004462